Knee osteoarthritis and cell-based treatments

Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read

Start with the cause of pain

Knee osteoarthritis affects the whole joint, including cartilage, bone and surrounding tissues. Pain severity does not always match a scan. Before considering a cell procedure, a clinician should assess the diagnosis, alignment, function and previous treatment. A recommendation based only on a photograph or a short message cannot replace that evaluation.

Different products need different evidence

Bone marrow concentrates, fat-derived preparations and manufactured cell products are not interchangeable. An approved product for a specific indication in one country does not validate every injection sold under the stem cell label. Ask for the exact product, proposed route, local authorization and the published evidence for patients with a similar severity of knee disease.

Measure a meaningful result

Less pain is not proof that new cartilage has grown. Ask whether the evidence measures pain, walking ability, imaging changes or avoidance of further treatment, and how long follow-up lasts. A practical goal might be improved daily function. The clinician should explain uncertainty and describe how the outcome will be measured before treatment begins.

Compare with the full care plan

Discuss strength and activity programs, weight management when relevant, appropriate medicines, braces and surgical assessment if indicated. Ask what rehabilitation follows the proposed procedure and what costs would arise if symptoms persist. Request a plan that can continue after you return home, including the circumstances that would trigger reassessment rather than repeated injections.

Continue exploring

• Acute myeloid leukemia and transplantation
• Acute lymphoblastic leukemia and transplantation
• Multiple myeloma and autologous transplant
• Prepare your consultation checklist

Sources & further reading

• Primary patient information and research

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.